Exchange
TWSE
Every company in the roster listed on TWSE.
Research
Compare financial metrics on this exchange
Research adds market cap, cash, runway and annualized R&D metrics with metric-specific sorting.
Views
2 of 2 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 Upsher-Smith Laboratories, LLC6472 · TWSE | 2 assets: 2 approved | Approved assets only | None on record |
 Polaris Group6550 · TWSE | 1 asset: 1 Ph 3 | PegargiminasePhase 3 · Acute Myeloid LeukemiaWeak signal | 28 Feb 2027Pegargiminase · Phase 2 |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).